Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001144204-13-006185
Filing Date
2013-02-05
Accepted
2013-02-05 17:14:04
Documents
1
Period of Report
2013-02-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v334015_4.html 4  
1 OWNERSHIP DOCUMENT v334015_4.xml 4 3202
  Complete submission text file 0001144204-13-006185.txt   4674
Mailing Address 80 WEST SIERRA MADRE BLVD., #392 SIERRA MADRE CA 91024
Business Address 80 WEST SIERRA MADRE BLVD., #392 SIERRA MADRE CA 91024 626-227-1630
INNOVUS PHARMACEUTICALS, INC. (Issuer) CIK: 0001411879 (see all company filings)

EIN.: 870324697 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 6770 Blank Checks

Mailing Address C/O BIO-QUANT, INC. 6330 NANCY RIDGE DRIVE, SUITE 103 SAN DIEGO CA 92121
Business Address
Damaj Bassam (Reporting) CIK: 0001478733 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52991 | Film No.: 13574924